Analyze Regeneron Pharm (REGN) financial statement. You need to use 10-K data that comes from www.sev.gov
1. Analyze Regeneron Pharm (REGN)'s Financial Liabilities and Leases at end of 2015.
a. Comment on the sources of capital coming from debt securities and leases for your firm.
b. What proportion of this capital is composed of debt? What proportion is composed of capital/financial leases?
c. Estimate the value of operating leases.
d. Adjust the debt to equity ratio for the value of those operating leases and discuss the impact.
e. Comment on the differences/similarities of the debt/leasing decisions of your firm relative to your competitor.
2. Analyze Regeneron Pharm (REGN)'s Income tax reporting at end of 2015 Income tax reporting
a. Comment on the differences between taxes paid/payable and provision for taxes.
b. Comment on the sources of the difference between the US federal statutory tax rate (35%) and the effective tax rate.
3. Analyze Regeneron Pharm (REGN)'s financial reporting quality (2015).
a. Evaluate the quality of your company's financial reports.
b. Evaluate the earnings quality of your company.
c. Evaluate the cash flow quality of your company.
d. Evaluate the balance sheet quality of your company.
e. Identify all areas of concern that might impact the usefulness of your company's financial reports.